39 results
8-K
EX-99.1
NUVL
Nuvalent Inc - Ordinary Shares
9 May 24
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results
6:37am
. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome
8-K
EX-99.1
NUVL
Nuvalent Inc - Ordinary Shares
27 Feb 24
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
6:38am
in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse
8-K
EX-99.1
NUVL
Nuvalent Inc - Ordinary Shares
9 Jan 24
Nuvalent Announces “OnTarget 2026” Operating Plan and Key Anticipated Milestones
4:40pm
develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more
8-K
EX-99.1
k1gnwmcjobfz
14 Nov 23
Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter
6:45am
8-K
EX-99.1
pq5g7h2oct1ed
17 Oct 23
Nuvalent Announces Pricing of Public Offering of Common Stock
4:07pm
424B5
prbq8xvtig2
17 Oct 23
Prospectus supplement for primary offering
4:05pm
424B5
t9xtga97lhh4wjaj
16 Oct 23
Prospectus supplement for primary offering
7:39am
8-K
EX-99.1
vpau6fh0 c3n8g5
13 Oct 23
Nuvalent Reports Preliminary Phase 1 Clinical Data from ALKOVE-1 Trial
6:40am
8-K
EX-99.1
fi4b1dicmsy
4 Oct 23
Other Events
4:05pm
8-K
EX-99.1
0vxm j59ce
10 Aug 23
Nuvalent Highlights Pipeline Progress and Reports Second Quarter 2023 Financial Results
6:45am
8-K
EX-99.1
vvr7e4uck
11 May 23
Nuvalent Announces Anticipated Timing of Preliminary Phase 1 Dose-Escalation Data for NVL-655 and Reports First Quarter 2023 Financial Results
6:39am
8-K
EX-99.1
8fnhht4
10 Nov 22
Nuvalent Reviews Corporate and Pipeline Achievements and Reports Third Quarter 2022 Financial Results
6:37am
8-K
EX-99.1
jra8o4s b1rv5l2oftg6
1 Nov 22
Nuvalent Announces Pricing of Public Offering of Common Stock
5:19pm
424B5
flg9ed9u qw0s8r
1 Nov 22
Prospectus supplement for primary offering
5:17pm